The Fertility Crisis & Ending Genetic Disease w/ Noor Siddiqui, CEO of Orchid

19 Sept 2024 · 70 min
1:09:36

In this Upstream podcast episode, host Erik Torenberg interviews Noor Siddiqui, founder and CEO of Orchid, about the company’s breakthrough whole‑genome sequencing of embryos—a jump from the traditional ~1% chromosome‑count test to 99% coverage. Noor explains the technical stack (single‑cell sequencing, chemistry, bioinformatics) and why the confluence of cheaper sequencing, larger variant databases, and decades of genomics research made the breakthrough possible now. She frames the technology as a way to slash the incidence of rare monogenic diseases (which affect 30 million Americans collectively) and to provide polygenic risk scores for complex traits. The conversation moves to IVF’s role as the delivery platform, the growing stigma‑to‑normalization trajectory of reproductive technologies, and the ethical stance that parents have a responsibility to use available information to avoid severe disease in their children while preserving reproductive autonomy. Noor rejects eugenic associations, emphasizes that Orchid’s role is to provide accurate data and counseling, not to dictate choices. She discusses future directions such as in‑vitro gametogenesis and artificial wombs, and reflects on broader demographic trends: declining fertility rates, cultural shifts in dating and family formation, and the potential societal impact of a shrinking population versus a future with advanced AI. The later segment delves into a personal discussion on nature versus nurture in child development, with both host and guest sharing observations that parents often perceive a strong genetic component (roughly 75% nature, 25% nurture) and how this perception influences parenting attitudes. Noor also shares how her own over‑protective upbringing shaped her views. Finally, Noor outlines the practical workflow for parents interested in Orchid: nationwide availability, online portal (orchidhealth.com), genetic counseling, partnership with pre‑approved IVF centers, or onboarding of a preferred clinic, leading to the same IVF process but with a vastly richer genomic report on each embryo.

Chapters

More from Erik

49:52
youtube.com

How to Spot Exceptional Talent Before Everyone Else

3w ago
26:15
youtube.com

"Meme Your Dream into Reality" | Replit CEO with a16z

3mo ago
46:31
youtube.com

The New Media Playbook with Marc Andreessen & Ben Horowitz

7mo ago
1:02:55
youtube.com

The Bronze Age Collapse and History's Selective Memory

1y ago
45:43
youtube.com

Why Industrial Revolutions Stall

1y ago
29:35
youtube.com

America’s Tech Strategy w/ Qasar Younis, Sen. Jack Reed, and Josh Wolfe

1y ago
31:09
youtube.com

Palantir CEO Alex Karp & Rep. Ritchie Torres on Innovation & The West | Hill and Valley Forum 2024

1y ago
1:20:45
youtube.com

Helen Toner OpenAI Reflections, Adaptation Buffers, and AI in Warfare

1y ago
1:02:46
youtube.com

Trump V2: Tariffs, American Dynamism, Higher Ed | Byrne Hobart

1y ago
0:49
youtube.com

💸 The INVENTION That Rewrote Finance Rules

1y ago
58:25
youtube.com

The Problem With Reserve Currencies and Switching to Crypto w/ Lyn Alden

1y ago
See all content